These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1200773)

  • 21. Effects of acute marijuana smoking on pulse rate and mood states in women.
    Lex BW; Mendelson JH; Bavli S; Harvey K; Mello NK
    Psychopharmacology (Berl); 1984; 84(2):178-87. PubMed ID: 6438677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delta9-tetrahydrocannabivarin as a marker for the ingestion of marijuana versus Marinol: results of a clinical study.
    ElSohly MA; deWit H; Wachtel SR; Feng S; Murphy TP
    J Anal Toxicol; 2001 Oct; 25(7):565-71. PubMed ID: 11599601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aspects of tolerance to and dependence on cannabis.
    Wikler A
    Ann N Y Acad Sci; 1976; 282():126-47. PubMed ID: 828472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Marijuana: dose-response effects on pulse rate, subjective estimates of potency, pleasantness, and recognition memory.
    Miller L; Cornett T; Drew W; McFarland D; Brightwell D; Wikler A
    Pharmacology; 1977; 15(3):268-75. PubMed ID: 325580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tolerance development to the effect of delta9-tetrahydrocannabinol on conditioned behavior: role of treatment interval and influence of microsomal metabolism.
    Davis WM; Borgen LA
    Arch Int Pharmacodyn Ther; 1975 Jan; 213(1):97-112. PubMed ID: 1156021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction between naltrexone and oral THC in heavy marijuana smokers.
    Haney M; Bisaga A; Foltin RW
    Psychopharmacology (Berl); 2003 Feb; 166(1):77-85. PubMed ID: 12491025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of expectancies on subjective responses to oral delta9-tetrahydrocannabinol.
    Kirk JM; Doty P; De Wit H
    Pharmacol Biochem Behav; 1998 Feb; 59(2):287-93. PubMed ID: 9476972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An analysis of the subjective marijuana experience.
    Adamec C; Pihl RO; Leiter L
    Int J Addict; 1976; 11(2):295-307. PubMed ID: 942628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis.
    D'Souza DC; Ranganathan M; Braley G; Gueorguieva R; Zimolo Z; Cooper T; Perry E; Krystal J
    Neuropsychopharmacology; 2008 Sep; 33(10):2505-16. PubMed ID: 18185500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Marijuana withdrawal in humans: effects of oral THC or divalproex.
    Haney M; Hart CL; Vosburg SK; Nasser J; Bennett A; Zubaran C; Foltin RW
    Neuropsychopharmacology; 2004 Jan; 29(1):158-70. PubMed ID: 14560320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the subjective effects of Delta(9)-tetrahydrocannabinol and marijuana in humans.
    Wachtel SR; ElSohly MA; Ross SA; Ambre J; de Wit H
    Psychopharmacology (Berl); 2002 Jun; 161(4):331-9. PubMed ID: 12073159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opioid antagonism of cannabinoid effects: differences between marijuana smokers and nonmarijuana smokers.
    Haney M
    Neuropsychopharmacology; 2007 Jun; 32(6):1391-403. PubMed ID: 17091128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study.
    van der Pol P; Liebregts N; Brunt T; van Amsterdam J; de Graaf R; Korf DJ; van den Brink W; van Laar M
    Addiction; 2014 Jul; 109(7):1101-9. PubMed ID: 24628797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute marijuana effects on social conversation.
    Higgins ST; Stitzer ML
    Psychopharmacology (Berl); 1986; 89(2):234-8. PubMed ID: 3088642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of marijuana smoking on subjective ratings and tobacco smoking.
    Nemeth-Coslett R; Henningfield JE; O'Keeffe MK; Griffiths RR
    Pharmacol Biochem Behav; 1986 Sep; 25(3):659-65. PubMed ID: 3774833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of treatment of Tourette syndrome with delta9-tetrahydrocannabinol (delta9-THC) on neuropsychological performance.
    Müller-Vahl KR; Koblenz A; Jöbges M; Kolbe H; Emrich HM; Schneider U
    Pharmacopsychiatry; 2001 Jan; 34(1):19-24. PubMed ID: 11229617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Odor and marijuana intoxication.
    Pihl RO; Shea D; Costa L
    J Clin Psychol; 1978 Jul; 34(3):775-9. PubMed ID: 690226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms.
    Budney AJ; Vandrey RG; Hughes JR; Moore BA; Bahrenburg B
    Drug Alcohol Depend; 2007 Jan; 86(1):22-9. PubMed ID: 16769180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of tetrahydrocannabinol content on marijuana smoking behavior, subjective reports, and performance.
    Heishman SJ; Stitzer ML; Yingling JE
    Pharmacol Biochem Behav; 1989 Sep; 34(1):173-9. PubMed ID: 2560548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating the impact of hemp food consumption on workplace drug tests.
    Leson G; Pless P; Grotenhermen F; Kalant H; ElSohly MA
    J Anal Toxicol; 2001; 25(8):691-8. PubMed ID: 11765026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.